全文获取类型
收费全文 | 3848篇 |
免费 | 235篇 |
国内免费 | 20篇 |
专业分类
耳鼻咽喉 | 18篇 |
儿科学 | 99篇 |
妇产科学 | 40篇 |
基础医学 | 529篇 |
口腔科学 | 85篇 |
临床医学 | 289篇 |
内科学 | 906篇 |
皮肤病学 | 238篇 |
神经病学 | 236篇 |
特种医学 | 75篇 |
外科学 | 457篇 |
综合类 | 24篇 |
预防医学 | 249篇 |
眼科学 | 81篇 |
药学 | 304篇 |
中国医学 | 16篇 |
肿瘤学 | 457篇 |
出版年
2023年 | 24篇 |
2022年 | 43篇 |
2021年 | 67篇 |
2020年 | 52篇 |
2019年 | 45篇 |
2018年 | 66篇 |
2017年 | 67篇 |
2016年 | 89篇 |
2015年 | 101篇 |
2014年 | 129篇 |
2013年 | 129篇 |
2012年 | 178篇 |
2011年 | 235篇 |
2010年 | 101篇 |
2009年 | 118篇 |
2008年 | 181篇 |
2007年 | 200篇 |
2006年 | 213篇 |
2005年 | 231篇 |
2004年 | 210篇 |
2003年 | 245篇 |
2002年 | 232篇 |
2001年 | 98篇 |
2000年 | 117篇 |
1999年 | 86篇 |
1998年 | 54篇 |
1997年 | 37篇 |
1996年 | 43篇 |
1995年 | 38篇 |
1994年 | 36篇 |
1993年 | 28篇 |
1992年 | 48篇 |
1991年 | 61篇 |
1990年 | 46篇 |
1989年 | 47篇 |
1988年 | 54篇 |
1987年 | 46篇 |
1986年 | 47篇 |
1985年 | 51篇 |
1984年 | 24篇 |
1983年 | 17篇 |
1981年 | 13篇 |
1980年 | 10篇 |
1979年 | 10篇 |
1978年 | 12篇 |
1977年 | 17篇 |
1976年 | 10篇 |
1975年 | 11篇 |
1974年 | 18篇 |
1969年 | 11篇 |
排序方式: 共有4103条查询结果,搜索用时 15 毫秒
991.
992.
Tomotaka Kawayama Kazuko Matsunaga Yoichiro Kaku Kyoko Yamaguchi Takashi Kinoshita Paul M O’Byrne Tomoaki Hoshino 《Allergology international》2013,62(2):203-213
BackgroundDetails of the comparisons between airway and peripheral blood regulatory T cells (Tregs) in patients with atopic asthma are still unclear. The objective of this study is to investigate the profiles of both airway and circulating Tregs in atopic asthma.MethodsWe measured the numbers of Tregs and eosinophils in induced sputum and peripheral blood in 28 patients with mild atopic asthma and compared these with numbers in 18 healthy controls. The frequency (%) of Tregs (surface CTLA4+, intracellular Foxp3+, and CTLA4+Foxp3+ on CD25highCD4+ T cells) in sputum and blood was determined by intracellular 5-color flow cytometry. We also correlated the numbers with the level of airway hyperresponsiveness (AHR) in asthmatics.ResultsThe mean frequencies of cells expressing CTLA4+ (19.4 ± 2.1%, p = 0.075), Foxp3+ (16.4 ± 3.3%, p = 0.001), and CTLA4+Foxp3+ (7.0 ± 1.1%, p = 0.008) in induced sputum from asthmatics were significantly lower than controls (27.2 ± 3.7%, 37.4 ± 4.7%, and 18.2 ± 3.6%, respectively), whereas in peripheral blood, there was no inter-group difference in the frequencies of cells expressing CTLA4+ (7.1 ± 1.5% vs 5.7 ± 1.7%, p > 0.05), Foxp3+ (35.7 ± 3.2% vs 21.1 ± 3.9%, p > 0.05), and CTLA4+Foxp3+ (6.6 ± 1.5% vs 4.2 ± 1.0%, p > 0.05). Moreover, the frequency of CD25highCD4+ cells expressing CTLA4+, but not Foxp3+, in induced sputum was associated with AHR (r = 0.60, p = 0.009) and airway eosinophilic inflammation (r = ? 0.60, p = 0.008) in asthmatics.ConclusionsAirway, but not circulating, Tregs are decreased in mild atopic asthmatics, and are negatively correlated to an increase of airway eosinophilic inflammation and AHR. 相似文献
993.
994.
995.
Yukihiko Saeki Eriko Kudo-Tanaka Shiro Ohshima Masato Matsushita So-ichiro Tsuji Yu-ichi Maeda Maiko Yoshimura Akane Watanabe Yoshinori Katada Yoshinori Harada Kenji Ichikawa Yasuo Suenaga Yusuke Ohta Shigeto Tohma 《Rheumatology international》2013,33(2):451-456
A prospective study was made to seek for a convenient biomarker to predict progression of bone destruction (PBD) in early stages of rheumatoid arthritis (ERA). All participated patients had definite RA and their radiographic stages were mild less than stage II of the Steinbrocker classification, naïve for treatment of any DMARDs or corticosteroids. After the entry, they were treated according to the 2002 ACR management guideline for RA. The candidate biomarkers (RF-IgM, RF-IgG, CARF, ACPA, CRP, ESR, NTx, MMP-3, IL-6 and osteopontin) were measured at the entry. PBD was assessed radiographically by interval changes in the modified Sharp scores (ΔSHS) for 24 months. The associations between ΔSHS and baseline biomarkers were assessed statistically by multivariate regression analyses. Both the baseline ACPA and IL-6 levels correlated with PBD, suggesting that they could predict PBD in ERA. 相似文献
996.
Excessive exposure to anionic surfaces maintains autoantibody response to beta(2)-glycoprotein I in patients with antiphospholipid syndrome
下载免费PDF全文
![点击此处可从《Blood》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Antiphospholipid syndrome (APS) is an autoimmune prothrombotic disorder associated with autoantibodies to phospholipid (PL)-binding proteins, such as beta(2)-glycoprotein I (beta(2)GPI). We have recently reported that binding of beta(2)GPI to anionic PL facilitates processing and presentation of the cryptic beta(2)GPI epitope that activates pathogenic autoreactive T cells. To clarify mechanisms that induce sustained presentation of the dominant antigenic beta(2)GPI determinant in patients with APS, T-cell proliferation induced by beta(2)GPI-treated phosphatidylserine liposome (beta(2)GPI/PS) was evaluated in bulk peripheral blood mononuclear cell cultures. T cells from patients with APS responded to beta(2)GPI/PS in the presence of immunoglobulin G (IgG) anti-beta(2)GPI antibodies derived from APS plasma, and this response was completely inhibited either by the depletion of monocytes or by the addition of anti-FcgammaRI antibody. These findings indicate that efficient presentation of the cryptic determinants can be achieved by monocytes undergoing FcgammaRI-mediated uptake of beta(2)GPI-bound anionic surfaces in the presence of IgG anti-beta(2)GPI antibodies. Finally, beta(2)GPI-bound oxidized LDL or activated platelets also induced the specific T-cell response. Continuous exposure to these anionic surfaces may play a critical role in maintaining the pathogenic anti-beta(2)GPI antibody response in patients with APS. 相似文献
997.
Takabayashi R Nishikido O Nagano K Doi A Nishisako R Tateda T 《Masui. The Japanese journal of anesthesiology》2007,56(10):1198-1199
May-Hegglin anomaly (MHA) is a rare hereditary disorder characterized by thrombocytopenia and giant thrombocytes and continuous appearance of inclusion bodies (Dohle like corpuscles) in the cytoplasm of granulocytes. A 26-year-old woman with MHA underwent cesarean delivery under general anesthesia, although she had no history of bleeding. The platelet count was 4.9x10(4) microgl(-1) the day before surgery. There was no unusual bleeding during and after the operation and we did not give her platelet transfusion. 相似文献
998.
999.
Shem K 《The journal of spinal cord medicine》2008,31(4):398-402
Objective:
To describe a complication of placement of an inferior vena cava (IVC) filter in a man with paraplegia.Design:
Case report.Participants/Methods:
A 48-year-old man with T11 paraplegia secondary to an L1 burst fracture underwent thoracic spinal fusion. The postoperative course was complicated by deep vein thrombosis (DVT) of the right common femoral vein, which was treated with warfarin.Results:
During rehabilitation, the hematocrit declined, and fluctuance was noted along the surgical site. Computed tomographic scan suggested a hematoma in the paraspinal and latissimus dorsi muscles. Warfarin was discontinued, and an IVC filter was placed. He subsequently developed severe leg pain, followed by hypotension, acute renal failure, and compartment syndrome in bilateral lower extremities requiring fasciotomies. Ultrasound and computed tomographic angiogram showed extensive bilateral lower extremity DVTs and pulmonary emboli. The diagnosis of cerulea dolens was made. Mechanical and pharmacological thrombectomy was aborted secondary to bleeding complications and hypotension. The patient died shortly after care was withdrawn at the family''s request. The autopsy revealed multiple thrombi in IVC, bilateral pelvic and femoral veins, and left pulmonary artery embolus, consistent with phlegmasia cerulea dolens.Conclusions:
Inferior vena cava filters may prevent pulmonary embolism but do not affect the underlying thrombotic process. An IVC filter should be recognized as a possible thrombogenic nidus in patients with spinal cord injury who have known DVT. 相似文献1000.
Microparticles-adsorbed insulin and zinc insulin (PenfilN) were molded to self-dissolving micropiles (SDMPs) with chondroitin sulfate as the base for the percutaneous administration of insulin. Porous silicon dioxide (Sylysia 320, 440 and 730) and porous calcium silicate (FloriteRE) were used as microparticles. As a reference, insulin loaded SDMPs were prepared. SDMPs were percutaneously administered to mice at the insulin dose level of 2.5 IU/kg. After the insertion of SDMPs to mouse skin, blood samples were collected for 8 h and plasma glucose levels were measured. There were not significant differences on minimum plasma glucose levels between the test preparations. However, T(mins), the time when the minimum glucose level appeared were 1.5 +/- 0.2 h (Sylysia 320), 1.3 +/- 0.2 h (Sylysia 440), 1.6 +/- 0.4 h (Sylysia 730), 2.1 +/- 0.3 h (Florite) and 1.7 +/- 0.3 h (zinc insulin) which were greater than insulin SDMP, 0.8 +/- 0.1 h. In addition, greater hypoglycemic effects were observed with SDMPs containing adsorbent-insulin and/or zinc insulin than insulin SDMP. The mean AACs (area above the plasma glucose level vs. time curve) of SDMPs containing adsorbent-insulin and zinc insulin were 357.8% h for FloriteRE, 333.1% h for Sylysia 320, 308.1% h for Sylysia 440, 328.1% h for Sylysia 730, and 374.7% h for zinc insulin, respectively, which were about two folds higher than that of insulin SDMN, 161.2% h. Those results suggest the usefulness of SDMPs composed of adsorbent-insulin as a long-acting percutaneous insulin preparation. 相似文献